PodcastsPodcasts

The Clinical Utility of Guselkumab in CD

Simplifying Access: Prior Authorization Part 1

Simplifying Access: Prior Authorization Part 2

Simplifying Access: Evolving Drug Distribution Channels

GHAPPcast: The Clinical Utility of Guselkumab in UC

GHAPPcast Part 3: Provider & Patient Support

GHAPPcast Part 2: Diagnosis and Management

GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis

GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis

Building a Sense of Urgency for PBC Patient Evaluation/Monitoring

Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy

Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy

Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression

Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically

Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively

Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA

GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey

GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play